PRACA ORYGINALNA
Rakotwórczość kadmu – kluczowe zagadnienia
 
Więcej
Ukryj
1
Laboratory for Environmental Health Research, Institute for Biomedical Research Head Assoc. Prof. DSc O. Abdrachmanovas Director of Institute for Biomedical Research Prof. dr. hab. A. Tamasauskas
2
Department of Surgery, Medical Academy, Lithuanian University of Health Sciences, Kaunas, Lithuania Rector of Lithuanian University of Health Sciences Prof. dr. hab. R. Zaliunas
AUTOR DO KORESPONDENCJI
Loreta Strumylaite   

Institute for Biomedical Research Medical Academy Lithuanian University of Health Sciences Eiveniu 4 LT-50009 Kaunas Lithuania
 
Med Srod. 2011;14(3):13–15
 
SŁOWA KLUCZOWE
STRESZCZENIE ARTYKUŁU
Przedstawiono w skrócie główne mechanizmy karcinogenezy wywołanej przez kadm oraz najbardziej częste miejsca występowania nowotworu indukowanego przez kadm (płuca, piersi, prostata, jądra, nerki). Mimo wielu dowodów wykazujących działanie karcinogenne kadmu konieczne są dalsze badania, aby wyjaśnić względny udział różnych mechanizmów molekularnych biorących udział w karcinogenezie wywołanej przez kadm.

The article presents briefly the main mechanisms of cadmium carcinogenesis and the most important sites of cancer (lung, breast, prostate, testes, kidney) induced by cadmium. In spite of some evidence showing carcinogenic potential of cadmium, further research is still required to elucidate the relative contributions of various molecular mechanisms involved in cadmium carcinogenesis.
 
REFERENCJE (16)
1.
Jarup L.: Hazards of heavy metal contamination. British Med Bull 2003; 68:167-182.
 
2.
International Agency for Research on Cancer (IARC). IARC Monographs on Monographs on the evaluation of carcinogenic risks to humans. IARC, Lyon, 1993:119–237.
 
3.
Waalkes M.P.: Cadmium carcinogenesis in review. J Inorg Bioch 2000; 79:241–244.
 
4.
Joseph P.: Mechanisms of cadmium carcinogenesis. Toxicol Appl Pharmacol 2009; 38:272–279.
 
5.
Satarug S., Baker J.R., Urbenjapol S., et al.: Global perspective on cadmium pollution and toxicity in non-occupationally exposed population. Toxicol Lett 2003; 137:65– 83.
 
6.
Klaassen C.D., Liu J., Choudhuri S.: Metallothionein: an intracellular protein to protect against cadmium toxicity. Ann Rev Pharmacol Toxicol 1999; 39:267–294.
 
7.
Pearson C.A., Prosealeck W.C.: E cadherin, B–catenin and cadmium carcinogenesis. Medical Hypothesis 2001; 56(5):573–581.
 
8.
Stoica A., Katzenellenbogen B.S., Martin M.B.: Activation of estrogen receptor-alpha by the heavy metal cadmium. Mol Endocrinol 2000; 14:545–553.
 
9.
Johnson M.D., Kenney N., Stoica A.: Cadmium mimics the in vivo effects of estrogen in the uterus and mammary gland. Nat Med 2003; 9:1081–1084.
 
10.
Strumylaite L., Bogusevicius A., Ryselis S., et al.: Association between cadmium and breast cancer. Medicina (Kaunas) 2008; 44:415–420.
 
11.
Strumylaite L., Bogusevicius A., Abrachmanovas O., et al.: Cadmium concentration in biological media of breast cancer patients. Breast cancer Res Treat 2011; 125:511–517.
 
12.
McElroy J.A., Shafer M.M., Trentham-Dietz A.: Cadmium exposure and breast cancer risk. J Natl Cancer Inst 2006; 98:869–872.
 
13.
Goyer R.A., Liu J., Waalkes M.P.: Cadmium and cancer of prostate and testis. BioMetals 2004; 17:555–558.
 
14.
Achanzar W.E., Webber M.W., Waalkes M.P.: Altered apoptotic gene expression and acquired apoptotic resistance in cadmium transformed human epithelial cells. The Prostate 2002; 52:236–244.
 
15.
Curti B.D.: Renal cell carcinoma. JAMA 2004; 292:97– 100.
 
16.
Hu J., Mao Y., White K.: Renal cell carcinoma and occupational exposure to chemicals in Canada. Occup Med 2002; 52:157–164.
 
eISSN:2084-6312
ISSN:1505-7054